Literature DB >> 3961829

The effect of nicardipine on neuronal function following ischemia.

J Grotta, J Spydell, C Pettigrew, P Ostrow, D Hunter.   

Abstract

In cerebral ischemia, it has been proposed that calcium influx into neurons results in irreversible cellular injury during reperfusion. We administered nicardipine, a dihydropyridine calcium entry blocker, by continuous subcutaneous infusion to twenty five rats beginning before (PR) or following (PO) ischemia, and compared somatosensory evoked potentials (SEPs) to twenty eight ischemic control animals. Comparable ischemic cellular changes were seen in the hippocampi of all animals. SEP amplitude was higher in both the PR (p less than .005) and PO (p less than .0005) groups compared to controls. This effect was found in all three components (P1, N1, P2) of the evoked response. Plasma nicardipine levels of 6-10 ng/ml were associated with mild hypotension. We conclude that nicardipine improved neuronal function as measured by SEPs when administered before or after ischemia, most likely by interrupting the cytotoxic events occurring in cortical neurons during reperfusion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3961829     DOI: 10.1161/01.str.17.2.213

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Effect of nicardipine on somatosensory evoked potentials in patients with acute cerebral infarction.

Authors:  L P Yao; D Y Ding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

2.  Molecular genetics of serine and threonine catabolism in Saccharomyces cerevisiae.

Authors:  J G Petersen; M C Kielland-Brandt; T Nilsson-Tillgren; C Bornaes; S Holmberg
Journal:  Genetics       Date:  1988-07       Impact factor: 4.562

3.  Effects of emopamil on postischemic blood flow and neuronal damage in rat brain.

Authors:  G W Bielenberg; D Sauer; J Nuglisch; T Beck; C Rossberg; H D Mennel; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

4.  The effects of nicardipine given after 10-minutes complete global cerebral ischemia on neurologic recovery in dogs.

Authors:  N Iwatsuki; K Ono; M Takahashi; T Tajima
Journal:  J Anesth       Date:  1990-10       Impact factor: 2.078

5.  Effects of nicardipine treatment on Na(+)-K+ ATPase and lipid peroxidation after experimental subarachnoid haemorrhage.

Authors:  F Marzatico; P Gaetani; G Spanu; E Buratti; R Rodriguez y Baena
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 6.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

7.  Regional depletion of adenosine triphosphate, phosphocreatine, and glucose in ischemic hippocampus.

Authors:  L C Pettigrew; J C Grotta; H M Rhoades; C Reid; D W McCandless
Journal:  Metab Brain Dis       Date:  1988-09       Impact factor: 3.584

8.  The Oxford study of Calcium channel Antagonism, Cognition, Mood instability and Sleep (OxCaMS): study protocol for a randomised controlled, experimental medicine study.

Authors:  Lauren Z Atkinson; Lucy Colbourne; Alexander Smith; Catherine H Harmer; Anna C Nobre; Jennifer Rendell; Helen Jones; Christopher Hinds; Arne Mould; Elizabeth M Tunbridge; Andrea Cipriani; John R Geddes; Kate E A Saunders; Paul J Harrison
Journal:  Trials       Date:  2019-02-12       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.